Development of core-shell scaffold with GelMA for cell encapsulation
There are around 20 million Type 1 diabetic patients worldwide and the only curative treatment involves islet transplantation. However, the shortage of donors and lifelong immunosuppression side effect drives the need for new regeneration treatment. Among all the approaches, cell encapsulation appea...
Saved in:
| 主要作者: | |
|---|---|
| 其他作者: | |
| 格式: | Final Year Project |
| 語言: | English |
| 出版: |
2018
|
| 主題: | |
| 在線閱讀: | http://hdl.handle.net/10356/74204 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
| 機構: | Nanyang Technological University |
| 語言: | English |